The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Ocular Drug Excipient Market Research Report 2025
Synopsis
Excipients are important part of the drug development process and ensure that the formulation remains stable throughout the development process as well when it is administered. It is basically any other component of the drug outside the medicinal component as it acts as a vehicle or a carrier for the medicinal product. This way stability to the formulation is provided. Wrong selection of excipient can lead to complications like intoxication of the patients. In ocular drugs, they play an important role in maintaining the tonicity, pH, stability, viscosity and sterility of the formulation.
The global Ocular Drug Excipient market was valued at US$ 863 million in 2023 and is anticipated to reach US$ 1302.5 million by 2030, witnessing a CAGR of 6.1% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Ocular Drug Excipient, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ocular Drug Excipient.
Report Scope
The Ocular Drug Excipient market size, estimations, and forecasts are provided in terms of output/shipments (Kiloton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ocular Drug Excipient market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ocular Drug Excipient manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BASF
Beneo
Evonik
Excipact
Fuji Chemical Industries
InVitria
Innophos
JRS Pharma
IOI Oleochemical
Millipore Sigma
Mallinckrodt Pharmaceuticals
Pfanstiehl
PerkinElmer
Natoli
DFE Pharma
Segment by Type
Organic Compounds
Inorganic Compounds
Segment by Application
Pharmaceutical Companies
Biopharmaceutical Companies
Contract Manufacturing Organizations (CMOs)
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ocular Drug Excipient manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Ocular Drug Excipient by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Ocular Drug Excipient in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Excipients are important part of the drug development process and ensure that the formulation remains stable throughout the development process as well when it is administered. It is basically any other component of the drug outside the medicinal component as it acts as a vehicle or a carrier for the medicinal product. This way stability to the formulation is provided. Wrong selection of excipient can lead to complications like intoxication of the patients. In ocular drugs, they play an important role in maintaining the tonicity, pH, stability, viscosity and sterility of the formulation.
The global Ocular Drug Excipient market was valued at US$ 863 million in 2023 and is anticipated to reach US$ 1302.5 million by 2030, witnessing a CAGR of 6.1% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Ocular Drug Excipient, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ocular Drug Excipient.
Report Scope
The Ocular Drug Excipient market size, estimations, and forecasts are provided in terms of output/shipments (Kiloton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Ocular Drug Excipient market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ocular Drug Excipient manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BASF
Beneo
Evonik
Excipact
Fuji Chemical Industries
InVitria
Innophos
JRS Pharma
IOI Oleochemical
Millipore Sigma
Mallinckrodt Pharmaceuticals
Pfanstiehl
PerkinElmer
Natoli
DFE Pharma
Segment by Type
Organic Compounds
Inorganic Compounds
Segment by Application
Pharmaceutical Companies
Biopharmaceutical Companies
Contract Manufacturing Organizations (CMOs)
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Ocular Drug Excipient manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Ocular Drug Excipient by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Ocular Drug Excipient in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Ocular Drug Excipient Market Overview
1.1 Product Definition
1.2 Ocular Drug Excipient Segment by Type
1.2.1 Global Ocular Drug Excipient Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Organic Compounds
1.2.3 Inorganic Compounds
1.3 Ocular Drug Excipient Segment by Application
1.3.1 Global Ocular Drug Excipient Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Pharmaceutical Companies
1.3.3 Biopharmaceutical Companies
1.3.4 Contract Manufacturing Organizations (CMOs)
1.3.5 Others
1.4 Global Market Growth Prospects
1.4.1 Global Ocular Drug Excipient Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Ocular Drug Excipient Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Ocular Drug Excipient Production Estimates and Forecasts (2019-2030)
1.4.4 Global Ocular Drug Excipient Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Ocular Drug Excipient Production Market Share by Manufacturers (2019-2024)
2.2 Global Ocular Drug Excipient Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Ocular Drug Excipient, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Ocular Drug Excipient Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Ocular Drug Excipient Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Ocular Drug Excipient, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Ocular Drug Excipient, Product Offered and Application
2.8 Global Key Manufacturers of Ocular Drug Excipient, Date of Enter into This Industry
2.9 Ocular Drug Excipient Market Competitive Situation and Trends
2.9.1 Ocular Drug Excipient Market Concentration Rate
2.9.2 Global 5 and 10 Largest Ocular Drug Excipient Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Ocular Drug Excipient Production by Region
3.1 Global Ocular Drug Excipient Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Ocular Drug Excipient Production Value by Region (2019-2030)
3.2.1 Global Ocular Drug Excipient Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Ocular Drug Excipient by Region (2025-2030)
3.3 Global Ocular Drug Excipient Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Ocular Drug Excipient Production by Region (2019-2030)
3.4.1 Global Ocular Drug Excipient Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Ocular Drug Excipient by Region (2025-2030)
3.5 Global Ocular Drug Excipient Market Price Analysis by Region (2019-2024)
3.6 Global Ocular Drug Excipient Production and Value, Year-over-Year Growth
3.6.1 North America Ocular Drug Excipient Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Ocular Drug Excipient Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Ocular Drug Excipient Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Ocular Drug Excipient Production Value Estimates and Forecasts (2019-2030)
4 Ocular Drug Excipient Consumption by Region
4.1 Global Ocular Drug Excipient Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Ocular Drug Excipient Consumption by Region (2019-2030)
4.2.1 Global Ocular Drug Excipient Consumption by Region (2019-2024)
4.2.2 Global Ocular Drug Excipient Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Ocular Drug Excipient Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Ocular Drug Excipient Consumption by Country (2019-2030)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Ocular Drug Excipient Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Ocular Drug Excipient Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Ocular Drug Excipient Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Ocular Drug Excipient Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Ocular Drug Excipient Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Ocular Drug Excipient Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Ocular Drug Excipient Production by Type (2019-2030)
5.1.1 Global Ocular Drug Excipient Production by Type (2019-2024)
5.1.2 Global Ocular Drug Excipient Production by Type (2025-2030)
5.1.3 Global Ocular Drug Excipient Production Market Share by Type (2019-2030)
5.2 Global Ocular Drug Excipient Production Value by Type (2019-2030)
5.2.1 Global Ocular Drug Excipient Production Value by Type (2019-2024)
5.2.2 Global Ocular Drug Excipient Production Value by Type (2025-2030)
5.2.3 Global Ocular Drug Excipient Production Value Market Share by Type (2019-2030)
5.3 Global Ocular Drug Excipient Price by Type (2019-2030)
6 Segment by Application
6.1 Global Ocular Drug Excipient Production by Application (2019-2030)
6.1.1 Global Ocular Drug Excipient Production by Application (2019-2024)
6.1.2 Global Ocular Drug Excipient Production by Application (2025-2030)
6.1.3 Global Ocular Drug Excipient Production Market Share by Application (2019-2030)
6.2 Global Ocular Drug Excipient Production Value by Application (2019-2030)
6.2.1 Global Ocular Drug Excipient Production Value by Application (2019-2024)
6.2.2 Global Ocular Drug Excipient Production Value by Application (2025-2030)
6.2.3 Global Ocular Drug Excipient Production Value Market Share by Application (2019-2030)
6.3 Global Ocular Drug Excipient Price by Application (2019-2030)
7 Key Companies Profiled
7.1 BASF
7.1.1 BASF Ocular Drug Excipient Corporation Information
7.1.2 BASF Ocular Drug Excipient Product Portfolio
7.1.3 BASF Ocular Drug Excipient Production, Value, Price and Gross Margin (2019-2024)
7.1.4 BASF Main Business and Markets Served
7.1.5 BASF Recent Developments/Updates
7.2 Beneo
7.2.1 Beneo Ocular Drug Excipient Corporation Information
7.2.2 Beneo Ocular Drug Excipient Product Portfolio
7.2.3 Beneo Ocular Drug Excipient Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Beneo Main Business and Markets Served
7.2.5 Beneo Recent Developments/Updates
7.3 Evonik
7.3.1 Evonik Ocular Drug Excipient Corporation Information
7.3.2 Evonik Ocular Drug Excipient Product Portfolio
7.3.3 Evonik Ocular Drug Excipient Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Evonik Main Business and Markets Served
7.3.5 Evonik Recent Developments/Updates
7.4 Excipact
7.4.1 Excipact Ocular Drug Excipient Corporation Information
7.4.2 Excipact Ocular Drug Excipient Product Portfolio
7.4.3 Excipact Ocular Drug Excipient Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Excipact Main Business and Markets Served
7.4.5 Excipact Recent Developments/Updates
7.5 Fuji Chemical Industries
7.5.1 Fuji Chemical Industries Ocular Drug Excipient Corporation Information
7.5.2 Fuji Chemical Industries Ocular Drug Excipient Product Portfolio
7.5.3 Fuji Chemical Industries Ocular Drug Excipient Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Fuji Chemical Industries Main Business and Markets Served
7.5.5 Fuji Chemical Industries Recent Developments/Updates
7.6 InVitria
7.6.1 InVitria Ocular Drug Excipient Corporation Information
7.6.2 InVitria Ocular Drug Excipient Product Portfolio
7.6.3 InVitria Ocular Drug Excipient Production, Value, Price and Gross Margin (2019-2024)
7.6.4 InVitria Main Business and Markets Served
7.6.5 InVitria Recent Developments/Updates
7.7 Innophos
7.7.1 Innophos Ocular Drug Excipient Corporation Information
7.7.2 Innophos Ocular Drug Excipient Product Portfolio
7.7.3 Innophos Ocular Drug Excipient Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Innophos Main Business and Markets Served
7.7.5 Innophos Recent Developments/Updates
7.8 JRS Pharma
7.8.1 JRS Pharma Ocular Drug Excipient Corporation Information
7.8.2 JRS Pharma Ocular Drug Excipient Product Portfolio
7.8.3 JRS Pharma Ocular Drug Excipient Production, Value, Price and Gross Margin (2019-2024)
7.8.4 JRS Pharma Main Business and Markets Served
7.7.5 JRS Pharma Recent Developments/Updates
7.9 IOI Oleochemical
7.9.1 IOI Oleochemical Ocular Drug Excipient Corporation Information
7.9.2 IOI Oleochemical Ocular Drug Excipient Product Portfolio
7.9.3 IOI Oleochemical Ocular Drug Excipient Production, Value, Price and Gross Margin (2019-2024)
7.9.4 IOI Oleochemical Main Business and Markets Served
7.9.5 IOI Oleochemical Recent Developments/Updates
7.10 Millipore Sigma
7.10.1 Millipore Sigma Ocular Drug Excipient Corporation Information
7.10.2 Millipore Sigma Ocular Drug Excipient Product Portfolio
7.10.3 Millipore Sigma Ocular Drug Excipient Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Millipore Sigma Main Business and Markets Served
7.10.5 Millipore Sigma Recent Developments/Updates
7.11 Mallinckrodt Pharmaceuticals
7.11.1 Mallinckrodt Pharmaceuticals Ocular Drug Excipient Corporation Information
7.11.2 Mallinckrodt Pharmaceuticals Ocular Drug Excipient Product Portfolio
7.11.3 Mallinckrodt Pharmaceuticals Ocular Drug Excipient Production, Value, Price and Gross Margin (2019-2024)
7.11.4 Mallinckrodt Pharmaceuticals Main Business and Markets Served
7.11.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
7.12 Pfanstiehl
7.12.1 Pfanstiehl Ocular Drug Excipient Corporation Information
7.12.2 Pfanstiehl Ocular Drug Excipient Product Portfolio
7.12.3 Pfanstiehl Ocular Drug Excipient Production, Value, Price and Gross Margin (2019-2024)
7.12.4 Pfanstiehl Main Business and Markets Served
7.12.5 Pfanstiehl Recent Developments/Updates
7.13 PerkinElmer
7.13.1 PerkinElmer Ocular Drug Excipient Corporation Information
7.13.2 PerkinElmer Ocular Drug Excipient Product Portfolio
7.13.3 PerkinElmer Ocular Drug Excipient Production, Value, Price and Gross Margin (2019-2024)
7.13.4 PerkinElmer Main Business and Markets Served
7.13.5 PerkinElmer Recent Developments/Updates
7.14 Natoli
7.14.1 Natoli Ocular Drug Excipient Corporation Information
7.14.2 Natoli Ocular Drug Excipient Product Portfolio
7.14.3 Natoli Ocular Drug Excipient Production, Value, Price and Gross Margin (2019-2024)
7.14.4 Natoli Main Business and Markets Served
7.14.5 Natoli Recent Developments/Updates
7.15 DFE Pharma
7.15.1 DFE Pharma Ocular Drug Excipient Corporation Information
7.15.2 DFE Pharma Ocular Drug Excipient Product Portfolio
7.15.3 DFE Pharma Ocular Drug Excipient Production, Value, Price and Gross Margin (2019-2024)
7.15.4 DFE Pharma Main Business and Markets Served
7.15.5 DFE Pharma Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Ocular Drug Excipient Industry Chain Analysis
8.2 Ocular Drug Excipient Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Ocular Drug Excipient Production Mode & Process
8.4 Ocular Drug Excipient Sales and Marketing
8.4.1 Ocular Drug Excipient Sales Channels
8.4.2 Ocular Drug Excipient Distributors
8.5 Ocular Drug Excipient Customers
9 Ocular Drug Excipient Market Dynamics
9.1 Ocular Drug Excipient Industry Trends
9.2 Ocular Drug Excipient Market Drivers
9.3 Ocular Drug Excipient Market Challenges
9.4 Ocular Drug Excipient Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of TablesList of Tables
Table 1. Global Ocular Drug Excipient Market Value by Type, (US$ Million) & (2023 VS 2030)
Table 2. Global Ocular Drug Excipient Market Value by Application, (US$ Million) & (2023 VS 2030)
Table 3. Global Ocular Drug Excipient Production Capacity (Kiloton) by Manufacturers in 2023
Table 4. Global Ocular Drug Excipient Production by Manufacturers (2019-2024) & (Kiloton)
Table 5. Global Ocular Drug Excipient Production Market Share by Manufacturers (2019-2024)
Table 6. Global Ocular Drug Excipient Production Value by Manufacturers (2019-2024) & (US$ Million)
Table 7. Global Ocular Drug Excipient Production Value Share by Manufacturers (2019-2024)
Table 8. Global Ocular Drug Excipient Industry Ranking 2022 VS 2023 VS 2024
Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Ocular Drug Excipient as of 2023)
Table 10. Global Market Ocular Drug Excipient Average Price by Manufacturers (US$/Ton) & (2019-2024)
Table 11. Manufacturers Ocular Drug Excipient Production Sites and Area Served
Table 12. Manufacturers Ocular Drug Excipient Product Types
Table 13. Global Ocular Drug Excipient Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion
Table 15. Global Ocular Drug Excipient Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 16. Global Ocular Drug Excipient Production Value (US$ Million) by Region (2019-2024)
Table 17. Global Ocular Drug Excipient Production Value Market Share by Region (2019-2024)
Table 18. Global Ocular Drug Excipient Production Value (US$ Million) Forecast by Region (2025-2030)
Table 19. Global Ocular Drug Excipient Production Value Market Share Forecast by Region (2025-2030)
Table 20. Global Ocular Drug Excipient Production Comparison by Region: 2019 VS 2023 VS 2030 (Kiloton)
Table 21. Global Ocular Drug Excipient Production (Kiloton) by Region (2019-2024)
Table 22. Global Ocular Drug Excipient Production Market Share by Region (2019-2024)
Table 23. Global Ocular Drug Excipient Production (Kiloton) Forecast by Region (2025-2030)
Table 24. Global Ocular Drug Excipient Production Market Share Forecast by Region (2025-2030)
Table 25. Global Ocular Drug Excipient Market Average Price (US$/Ton) by Region (2019-2024)
Table 26. Global Ocular Drug Excipient Market Average Price (US$/Ton) by Region (2025-2030)
Table 27. Global Ocular Drug Excipient Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Kiloton)
Table 28. Global Ocular Drug Excipient Consumption by Region (2019-2024) & (Kiloton)
Table 29. Global Ocular Drug Excipient Consumption Market Share by Region (2019-2024)
Table 30. Global Ocular Drug Excipient Forecasted Consumption by Region (2025-2030) & (Kiloton)
Table 31. Global Ocular Drug Excipient Forecasted Consumption Market Share by Region (2019-2024)
Table 32. North America Ocular Drug Excipient Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Kiloton)
Table 33. North America Ocular Drug Excipient Consumption by Country (2019-2024) & (Kiloton)
Table 34. North America Ocular Drug Excipient Consumption by Country (2025-2030) & (Kiloton)
Table 35. Europe Ocular Drug Excipient Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Kiloton)
Table 36. Europe Ocular Drug Excipient Consumption by Country (2019-2024) & (Kiloton)
Table 37. Europe Ocular Drug Excipient Consumption by Country (2025-2030) & (Kiloton)
Table 38. Asia Pacific Ocular Drug Excipient Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Kiloton)
Table 39. Asia Pacific Ocular Drug Excipient Consumption by Region (2019-2024) & (Kiloton)
Table 40. Asia Pacific Ocular Drug Excipient Consumption by Region (2025-2030) & (Kiloton)
Table 41. Latin America, Middle East & Africa Ocular Drug Excipient Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Kiloton)
Table 42. Latin America, Middle East & Africa Ocular Drug Excipient Consumption by Country (2019-2024) & (Kiloton)
Table 43. Latin America, Middle East & Africa Ocular Drug Excipient Consumption by Country (2025-2030) & (Kiloton)
Table 44. Global Ocular Drug Excipient Production (Kiloton) by Type (2019-2024)
Table 45. Global Ocular Drug Excipient Production (Kiloton) by Type (2025-2030)
Table 46. Global Ocular Drug Excipient Production Market Share by Type (2019-2024)
Table 47. Global Ocular Drug Excipient Production Market Share by Type (2025-2030)
Table 48. Global Ocular Drug Excipient Production Value (US$ Million) by Type (2019-2024)
Table 49. Global Ocular Drug Excipient Production Value (US$ Million) by Type (2025-2030)
Table 50. Global Ocular Drug Excipient Production Value Share by Type (2019-2024)
Table 51. Global Ocular Drug Excipient Production Value Share by Type (2025-2030)
Table 52. Global Ocular Drug Excipient Price (US$/Ton) by Type (2019-2024)
Table 53. Global Ocular Drug Excipient Price (US$/Ton) by Type (2025-2030)
Table 54. Global Ocular Drug Excipient Production (Kiloton) by Application (2019-2024)
Table 55. Global Ocular Drug Excipient Production (Kiloton) by Application (2025-2030)
Table 56. Global Ocular Drug Excipient Production Market Share by Application (2019-2024)
Table 57. Global Ocular Drug Excipient Production Market Share by Application (2025-2030)
Table 58. Global Ocular Drug Excipient Production Value (US$ Million) by Application (2019-2024)
Table 59. Global Ocular Drug Excipient Production Value (US$ Million) by Application (2025-2030)
Table 60. Global Ocular Drug Excipient Production Value Share by Application (2019-2024)
Table 61. Global Ocular Drug Excipient Production Value Share by Application (2025-2030)
Table 62. Global Ocular Drug Excipient Price (US$/Ton) by Application (2019-2024)
Table 63. Global Ocular Drug Excipient Price (US$/Ton) by Application (2025-2030)
Table 64. BASF Ocular Drug Excipient Corporation Information
Table 65. BASF Specification and Application
Table 66. BASF Ocular Drug Excipient Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 67. BASF Main Business and Markets Served
Table 68. BASF Recent Developments/Updates
Table 69. Beneo Ocular Drug Excipient Corporation Information
Table 70. Beneo Specification and Application
Table 71. Beneo Ocular Drug Excipient Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 72. Beneo Main Business and Markets Served
Table 73. Beneo Recent Developments/Updates
Table 74. Evonik Ocular Drug Excipient Corporation Information
Table 75. Evonik Specification and Application
Table 76. Evonik Ocular Drug Excipient Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 77. Evonik Main Business and Markets Served
Table 78. Evonik Recent Developments/Updates
Table 79. Excipact Ocular Drug Excipient Corporation Information
Table 80. Excipact Specification and Application
Table 81. Excipact Ocular Drug Excipient Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 82. Excipact Main Business and Markets Served
Table 83. Excipact Recent Developments/Updates
Table 84. Fuji Chemical Industries Ocular Drug Excipient Corporation Information
Table 85. Fuji Chemical Industries Specification and Application
Table 86. Fuji Chemical Industries Ocular Drug Excipient Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 87. Fuji Chemical Industries Main Business and Markets Served
Table 88. Fuji Chemical Industries Recent Developments/Updates
Table 89. InVitria Ocular Drug Excipient Corporation Information
Table 90. InVitria Specification and Application
Table 91. InVitria Ocular Drug Excipient Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 92. InVitria Main Business and Markets Served
Table 93. InVitria Recent Developments/Updates
Table 94. Innophos Ocular Drug Excipient Corporation Information
Table 95. Innophos Specification and Application
Table 96. Innophos Ocular Drug Excipient Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 97. Innophos Main Business and Markets Served
Table 98. Innophos Recent Developments/Updates
Table 99. JRS Pharma Ocular Drug Excipient Corporation Information
Table 100. JRS Pharma Specification and Application
Table 101. JRS Pharma Ocular Drug Excipient Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 102. JRS Pharma Main Business and Markets Served
Table 103. JRS Pharma Recent Developments/Updates
Table 104. IOI Oleochemical Ocular Drug Excipient Corporation Information
Table 105. IOI Oleochemical Specification and Application
Table 106. IOI Oleochemical Ocular Drug Excipient Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 107. IOI Oleochemical Main Business and Markets Served
Table 108. IOI Oleochemical Recent Developments/Updates
Table 109. Millipore Sigma Ocular Drug Excipient Corporation Information
Table 110. Millipore Sigma Specification and Application
Table 111. Millipore Sigma Ocular Drug Excipient Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 112. Millipore Sigma Main Business and Markets Served
Table 113. Millipore Sigma Recent Developments/Updates
Table 114. Mallinckrodt Pharmaceuticals Ocular Drug Excipient Corporation Information
Table 115. Mallinckrodt Pharmaceuticals Specification and Application
Table 116. Mallinckrodt Pharmaceuticals Ocular Drug Excipient Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 117. Mallinckrodt Pharmaceuticals Main Business and Markets Served
Table 118. Mallinckrodt Pharmaceuticals Recent Developments/Updates
Table 119. Pfanstiehl Ocular Drug Excipient Corporation Information
Table 120. Pfanstiehl Specification and Application
Table 121. Pfanstiehl Ocular Drug Excipient Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 122. Pfanstiehl Main Business and Markets Served
Table 123. Pfanstiehl Recent Developments/Updates
Table 124. PerkinElmer Ocular Drug Excipient Corporation Information
Table 125. PerkinElmer Specification and Application
Table 126. PerkinElmer Ocular Drug Excipient Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 127. PerkinElmer Main Business and Markets Served
Table 128. PerkinElmer Recent Developments/Updates
Table 129. Natoli Ocular Drug Excipient Corporation Information
Table 130. Natoli Specification and Application
Table 131. Natoli Ocular Drug Excipient Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 132. Natoli Main Business and Markets Served
Table 133. Natoli Recent Developments/Updates
Table 134. Natoli Ocular Drug Excipient Corporation Information
Table 135. DFE Pharma Specification and Application
Table 136. DFE Pharma Ocular Drug Excipient Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 137. DFE Pharma Main Business and Markets Served
Table 138. DFE Pharma Recent Developments/Updates
Table 139. Key Raw Materials Lists
Table 140. Raw Materials Key Suppliers Lists
Table 141. Ocular Drug Excipient Distributors List
Table 142. Ocular Drug Excipient Customers List
Table 143. Ocular Drug Excipient Market Trends
Table 144. Ocular Drug Excipient Market Drivers
Table 145. Ocular Drug Excipient Market Challenges
Table 146. Ocular Drug Excipient Market Restraints
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Ocular Drug Excipient
Figure 2. Global Ocular Drug Excipient Market Value by Type, (US$ Million) & (2023 VS 2030)
Figure 3. Global Ocular Drug Excipient Market Share by Type: 2023 VS 2030
Figure 4. Organic Compounds Product Picture
Figure 5. Inorganic Compounds Product Picture
Figure 6. Global Ocular Drug Excipient Market Value by Application, (US$ Million) & (2023 VS 2030)
Figure 7. Global Ocular Drug Excipient Market Share by Application: 2023 VS 2030
Figure 8. Pharmaceutical Companies
Figure 9. Biopharmaceutical Companies
Figure 10. Contract Manufacturing Organizations (CMOs)
Figure 11. Others
Figure 12. Global Ocular Drug Excipient Production Value (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Ocular Drug Excipient Production Value (US$ Million) & (2019-2030)
Figure 14. Global Ocular Drug Excipient Production Capacity (Kiloton) & (2019-2030)
Figure 15. Global Ocular Drug Excipient Production (Kiloton) & (2019-2030)
Figure 16. Global Ocular Drug Excipient Average Price (US$/Ton) & (2019-2030)
Figure 17. Ocular Drug Excipient Report Years Considered
Figure 18. Ocular Drug Excipient Production Share by Manufacturers in 2023
Figure 19. Ocular Drug Excipient Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 20. The Global 5 and 10 Largest Players: Market Share by Ocular Drug Excipient Revenue in 2023
Figure 21. Global Ocular Drug Excipient Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 22. Global Ocular Drug Excipient Production Value Market Share by Region: 2019 VS 2023 VS 2030
Figure 23. Global Ocular Drug Excipient Production Comparison by Region: 2019 VS 2023 VS 2030 (Kiloton)
Figure 24. Global Ocular Drug Excipient Production Market Share by Region: 2019 VS 2023 VS 2030
Figure 25. North America Ocular Drug Excipient Production Value (US$ Million) Growth Rate (2019-2030)
Figure 26. Europe Ocular Drug Excipient Production Value (US$ Million) Growth Rate (2019-2030)
Figure 27. China Ocular Drug Excipient Production Value (US$ Million) Growth Rate (2019-2030)
Figure 28. Japan Ocular Drug Excipient Production Value (US$ Million) Growth Rate (2019-2030)
Figure 29. Global Ocular Drug Excipient Consumption by Region: 2019 VS 2023 VS 2030 (Kiloton)
Figure 30. Global Ocular Drug Excipient Consumption Market Share by Region: 2019 VS 2023 VS 2030
Figure 31. North America Ocular Drug Excipient Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 32. North America Ocular Drug Excipient Consumption Market Share by Country (2019-2030)
Figure 33. Canada Ocular Drug Excipient Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 34. U.S. Ocular Drug Excipient Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 35. Europe Ocular Drug Excipient Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 36. Europe Ocular Drug Excipient Consumption Market Share by Country (2019-2030)
Figure 37. Germany Ocular Drug Excipient Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 38. France Ocular Drug Excipient Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 39. U.K. Ocular Drug Excipient Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 40. Italy Ocular Drug Excipient Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 41. Russia Ocular Drug Excipient Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 42. Asia Pacific Ocular Drug Excipient Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 43. Asia Pacific Ocular Drug Excipient Consumption Market Share by Regions (2019-2030)
Figure 44. China Ocular Drug Excipient Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 45. Japan Ocular Drug Excipient Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 46. South Korea Ocular Drug Excipient Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 47. China Taiwan Ocular Drug Excipient Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 48. Southeast Asia Ocular Drug Excipient Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 49. India Ocular Drug Excipient Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 50. Latin America, Middle East & Africa Ocular Drug Excipient Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 51. Latin America, Middle East & Africa Ocular Drug Excipient Consumption Market Share by Country (2019-2030)
Figure 52. Mexico Ocular Drug Excipient Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 53. Brazil Ocular Drug Excipient Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 54. Turkey Ocular Drug Excipient Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 55. GCC Countries Ocular Drug Excipient Consumption and Growth Rate (2019-2024) & (Kiloton)
Figure 56. Global Production Market Share of Ocular Drug Excipient by Type (2019-2030)
Figure 57. Global Production Value Market Share of Ocular Drug Excipient by Type (2019-2030)
Figure 58. Global Ocular Drug Excipient Price (US$/Ton) by Type (2019-2030)
Figure 59. Global Production Market Share of Ocular Drug Excipient by Application (2019-2030)
Figure 60. Global Production Value Market Share of Ocular Drug Excipient by Application (2019-2030)
Figure 61. Global Ocular Drug Excipient Price (US$/Ton) by Application (2019-2030)
Figure 62. Ocular Drug Excipient Value Chain
Figure 63. Ocular Drug Excipient Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
